Dr. Mark S. Litwin devotes his time to surgical care and research for patients with urologic cancers. His research activity focuses on quality of care and medical outcomes assessment, health-related quality of life, medical decision-making and prostate cancer in the underserved. He has published numerous quality-of-care and quality-of-life measures (including the UCLA Prostate Cancer Index) for use in men with prostate cancer. He has also published extensively on quality of care in patients with bladder and kidney cancer. His research has been continuously R-01 funded by the National Institutes of Health since 1997. He has also received grants from the American Cancer Society, Department of Defense, California Department of Public Health, and other organizations.

Litwin directs IMPACT (www.california-impact.org), a $73-million program for low-income, uninsured Californians with prostate cancer. He is also the principal investigator of Urologic Diseases in America (www.udaonline.net), a $14-million NIH project quantifying the burden of urologic diseases on the American public. His former fellows serve in academic positions throughout the world.